Acquired by Citrus TMG was recently acquired by Citrus Health Group, signaling a potential shift in strategic priorities and client footprint. Engage post-acquisition to understand new service needs, integration plans, and potential cross-sell opportunities across broader CNS and medical communications capabilities.

CNS Focus Specialization in central nervous system disorders and related therapeutic areas positions TMG as a partner for pharma with CNS products in development or launch. Target opportunities around publication planning, medical communications, and dissemination strategies for CNS clinical data.

Global Capability TMG emphasizes global strategic medical commercialization and publication planning. Approach multinational pharma with end-to-end life-cycle communication needs, including market access analyses, literature gap assessments, and strategic publication planning services.

Growth Scale With revenue in the mid-range and a lean team (11-50 employees), there may be room for scalable services, partnerships, or joint ventures to expand capabilities without large overhead. Propose modular service bundles that align with project scope and resource availability.

Digital & Tech Current tech stack includes iCIMS, DNS, Mimecast, and analytics tools, indicating readiness for streamlined marketing, recruitment, and data-driven insights. Leverage digital collaboration, secure communications, and analytics to offer more efficient program management and impact measurement for clients.